Inflammatory and Genetic Predictors of Cognitive and Emotional Recovery After Critical Illness

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCorporacion Parc Tauli

About this trial

Survivors of critical illness frequently develop persistent cognitive and emotional impairments, known as post-intensive care syndrome (PICS), which substantially impact quality of life and long-term recovery. While prior research has mainly focused on identifying risk factors, the mechanisms underlying resilience to these sequelae remain poorly understood. Emerging evidence suggests that biological factors, including inflammatory responses and genetic vulnerability, together with cognitive reserve, may play a key role in shaping recovery trajectories.

The aim of this multicenter, prospective observational study is to investigate how cognitive reserve, inflammatory phenotype, and genetic profiles interact to influence cognitive and emotional recovery after critical illness. Adult patients will be recruited at Intensive Care Unit (ICU) admission across two centers in Spain. Clinical and sociodemographic data will be collected during the ICU stay, and biological samples obtained early after admission will undergo transcriptomic and genetic analyses. Cognitive and emotional outcomes will be assessed at hospital discharge and at 3 and 12 months post-discharge using standardised neuropsychological and telemedicine-based evaluations.

By integrating clinical, biological, and cognitive data, this study seeks to identify recovery phenotypes and resilience mechanisms in PICS. The results may contribute to improved risk stratification, inform personalized interventions, and support the development of future strategies aimed at reducing the long-term burden of critical illness.

Eligibility criteria

Qualifiers

Adult patients (≥18 years)

Admitted to a medical-surgical ICU or cardiac ICU for causes of critical illness (e.g., acute pulmonary oedema, myocardial infarction, aortic dissection)

With or without the need for invasive mechanical ventilation

With an expected ICU stay of ≥48 hours

Disqualifiers

Non-authorisation by the patient and/or relatives for inclusion in the study

Patients admitted to a neurocritical ICU

History of severe neurological disease (including dementia or focal brain injury with functional and cognitive impairment) prior to ICU admission

History of severe psychiatric disorders (schizophrenia, bipolar disorder, major depressive disorder)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

114 Participants
are grouped into 2 trial groups

Locations

This trial has no locations

Sponsors and collaborators

Corporacion Parc Tauli

Lead sponsor

Hospital Universitario Central de Asturias

Collaborator